Company profile for RenovoRx

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

RenovoRx is developing innovative solutions for targeted delivery of fluids, including diagnostic and therapeutic agents such as chemotherapy, to selected sites in the peripheral vascular system. Delivering these agents at a high concentration to specific vasculature – safely and without perfusion to other regions – is a central paradigm of our technology. RenovoRx has developed the RenovoCath, which is FDA cleared and ...
RenovoRx is developing innovative solutions for targeted delivery of fluids, including diagnostic and therapeutic agents such as chemotherapy, to selected sites in the peripheral vascular system. Delivering these agents at a high concentration to specific vasculature – safely and without perfusion to other regions – is a central paradigm of our technology. RenovoRx has developed the RenovoCath, which is FDA cleared and now being investigated in an active clinical trial to prove extended median survival and improved quality of life.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
4546 El Camino Real Suite 223 Los Altos, CA 94022
Telephone
Telephone
(650) 284-4433
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/11/3203909/0/en/RenovoRx-Announces-Acceptance-of-Clinical-Data-Abstract-at-the-ASCO-Gastrointestinal-Cancers-Symposium-2026.html

GLOBENEWSWIRE
11 Dec 2025

https://www.globenewswire.com/news-release/2025/12/01/3196997/0/en/RenovoRx-CEO-Shaun-Bagai-to-Present-at-iAccess-Alpha-Virtual-Best-Ideas-Winter-Investment-Conference-2025-on-December-9th.html

GLOBENEWSWIRE
01 Dec 2025

https://www.globenewswire.com/news-release/2025/11/19/3190927/0/en/RenovoRx-CEO-Shaun-Bagai-to-Present-at-the-Alliance-Global-Partners-Emerging-AgBiotech-Bio-Solutions-Virtual-Showcase-on-November-20th.html

GLOBENEWSWIRE
19 Nov 2025

https://www.globenewswire.com/news-release/2025/11/13/3187826/0/en/RenovoRx-Reports-Third-Quarter-2025-Financial-Results-Including-Approximately-900-000-in-Year-to-Date-Revenue-and-Provides-Business-Update.html

GLOBENEWSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/11/06/3182592/0/en/RenovoRx-Strengthens-Scientific-Advisory-Board-SAB-with-Pancreatic-Cancer-Expert-Timothy-Donahue-MD.html

GLOBENEWSWIRE
06 Nov 2025

https://www.globenewswire.com/news-release/2025/11/04/3180350/0/en/RenovoRx-CEO-Shaun-Bagai-to-Participate-at-the-Canaccord-Genuity-MedTech-Diagnostics-Digital-Health-Services-Forum-on-November-20th.html

GLOBENEWSWIRE
04 Nov 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty